Filter
187
Text search:
monoclonal
antibodies
Featured
Recommendations
30
New Publications
32
Language
Document type
No document type
70
Guidelines
49
Studies & Reports
29
Manuals
17
Fact sheets
8
Strategic & Response Plan
5
Training Material
3
Resource Platforms
3
Situation Updates
2
Infographics
1
Countries / Regions
Global
17
India
14
South Africa
6
Germany
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
Philippines
3
Syria
3
Venezuela
3
Mali
2
Niger
2
Pakistan
2
Afghanistan
2
West and Central Africa
2
Middle East and North Africa
2
Africa
2
Russia
2
France
2
Spain
2
Burkina Faso
1
Sierra Leone
1
Liberia
1
Nigeria
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Ethiopia
1
Cameroon
1
Uganda
1
Haiti
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Chad
1
Tanzania
1
Rwanda
1
Mauritania
1
Sudan
1
Benin
1
Argentina
1
Dominican Republic
1
Namibia
1
Peru
1
Brazil
1
North Macedonia
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Western and Central Europe
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
41
Clinical Guidelines
31
Public Health
14
Pharmacy & Technologies
9
Women & Child Health
6
Capacity Building
2
Key Resources
2
Toolboxes
COVID-19
53
NTDs
13
Ebola & Marburg
12
HIV
10
NCDs
9
Malaria
9
Rapid Response
8
Polio
6
Pharmacy
5
Health Financing Toolbox
5
AMR
4
Cholera
3
Zika
3
Planetary Health
3
2.0 Rapid Response
3
Mental Health
2
Conflict
1
Natural Hazards
1
Refugee
1
Poster, 4 Janaury 2022
Accessed Nov. 28,2016
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,
...
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antib
...
The article reviews the impact of respiratory syncytial virus (RSV) on global health, emphasizing its significant burden on infants, children, and the elderly. It discusses current and emerging prevention strategies, including the development and implementation of vaccines and
...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi
...
Leishmaniasis is a vector-borne disease that is transmitted by sandflies and caused by obligate intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with 3 species (L. donovani, L. infantum, and
...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il
...
16.7.2021
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
Updated Treatment Guidelines
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
3 March 2016
